Articles

P2.01 Downregulation of cellular microRNA-150 is a new prognostic factor associated with a poor prognosis in Chronic Lymphocytic Leukemia patients

BJH - volume 5, issue Abstract Book BHS, january 2014

B. Stamatopoulos , N. Meuleman MD, PhD, E. Crompot , M. Van Damme , B. Dessars MD, PhD, H. El Housni , P. Mineur MD, D. Bron MD, PhD, L. Lagneaux

Read more

P2.04 Immune impairments of the multiple myeloma bone-marrow mesenchymal stromal cells

BJH - volume 5, issue Abstract Book BHS, january 2014

T. André , M. Najar , B. Stamatopoulos , K. Pieters , O. Pradier MD, PhD, D. Bron MD, PhD, N. Meuleman MD, PhD, L. Lagneaux

Read more

P2.05 Global HDAC enzymatic activity is a strong marker of poor prognosis in Chronic Lymphocytic Leukemia

BJH - volume 5, issue Abstract Book BHS, january 2014

M. Van Damme , E. Crompot , N. Meuleman MD, PhD, P. Mineur MD, B. Dessars MD, PhD, H. El Housni , D. Bron MD, PhD, L. Lagneaux , B. Stamatopoulos

Read more

P.04 HDAC in Chronic Lymphocytic Leukaemia: expression profile, enzymatic activity and prognostic significance

BJH - 2013, issue BHS Abstractbook, january 2013

M. Van Damme , E. Crompot , N. Meuleman MD, PhD, P. Mineur MD, D. Bron MD, PhD, L. Lagneaux , B. Stamatopoulos

Read more